Cowealth Medical China Stock Revenue
| 603122 Stock | 7.37 0.01 0.14% |
Cowealth Medical China fundamentals help investors to digest information that contributes to Cowealth Medical's financial success or failures. It also enables traders to predict the movement of Cowealth Stock. The fundamental analysis module provides a way to measure Cowealth Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cowealth Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 939.1 M | 885.1 M |
Cowealth | Revenue |
Cowealth Medical China Company Revenue Analysis
Cowealth Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Cowealth Medical Revenue | 939.14 M |
Most of Cowealth Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cowealth Medical China is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Cowealth Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Cowealth Medical China reported 939.14 M of revenue. This is 87.69% lower than that of the Biotechnology sector and 52.61% lower than that of the Health Care industry. The revenue for all China stocks is 90.05% higher than that of the company.
Cowealth Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cowealth Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cowealth Medical could also be used in its relative valuation, which is a method of valuing Cowealth Medical by comparing valuation metrics of similar companies.Cowealth Medical is currently under evaluation in revenue category among its peers.
Cowealth Fundamentals
| Return On Equity | 0.0243 | ||||
| Return On Asset | 0.0153 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 2.72 B | ||||
| Shares Outstanding | 398.05 M | ||||
| Shares Owned By Insiders | 57.57 % | ||||
| Shares Owned By Institutions | 0.63 % | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 3.12 X | ||||
| Revenue | 939.14 M | ||||
| Gross Profit | 184.09 M | ||||
| EBITDA | 44.69 M | ||||
| Net Income | 27.57 M | ||||
| Total Debt | 46.27 M | ||||
| Book Value Per Share | 2.68 X | ||||
| Cash Flow From Operations | 132.75 M | ||||
| Earnings Per Share | 0.07 X | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 2.93 B | ||||
| Total Asset | 1.49 B | ||||
| Retained Earnings | 129.31 M | ||||
| Working Capital | 972.28 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 1.49 B |
About Cowealth Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cowealth Medical China's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cowealth Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cowealth Medical China based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cowealth Stock
Cowealth Medical financial ratios help investors to determine whether Cowealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cowealth with respect to the benefits of owning Cowealth Medical security.